Cancer Drug Zevalin May Finally Thrive Under Spectrum
The small oncology company may be able to succeed with the non-Hodgkin lymphoma drug where others have failed.
The small oncology company may be able to succeed with the non-Hodgkin lymphoma drug where others have failed.